Skip to content
healthcare.dev

KOSELUGO

NDC 0310-0625, SELUMETINIB, capsule, from AstraZeneca Pharmaceuticals LP.

Product NDC
0310-0625
Status
Listed
Labeler
AstraZeneca Pharmaceuticals LP
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA213756
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0310-0625 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SELUMETINIB25 mg/1

Pharmacologic classes

Kinase Inhibitor [EPC]; Mitogen-Activated Protein Kinase Kinase 1 Inhibitors [MoA]; Mitogen-Activated Protein Kinase Kinase 2 Inhibitors [MoA]

Package NDCNDC-11Package
0310-0625-280031006252828 CAPSULE in 1 BOTTLE (0310-0625-28)
0310-0625-600031006256060 CAPSULE in 1 BOTTLE (0310-0625-60)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/7d042c61-f28f-4ab5-ab10-d7558c0d49ff

Use it

Look up 0310-0625 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0310-0625 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0310-0625. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.